The global healthcare landscape is witnessing a transformative surge in the market dedicated to **Epilepsy Diagnosis and Treatment**. Valued at a substantial USD 3.83 billion in 2024, this market is not merely growing; it is poised for an exponential leap, projected to skyrocket to a staggering USD 17.64 billion by the year 2035. This remarkable projection is underpinned by a robust Compound...